Abiopharma

🔍 McDonough Claire (Executive)

Company: Rivian Automotive, Inc. / DE (RIVN)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Sold 38,640 shares of Class A Common Stock at $15.36 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 840,345.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 13,144 shares of Class A Common Stock at $14.5047 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 827,201.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: 38,640 shares of Class A Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with the vesting of 75,940 Restricted Stock Units on August 15, 2026.
• F2: The closing price of the Issuer's Class A Common Stock on August 14, 2026.
• F3: The sale reported in this transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025, as described in the Issuer's Quarterly Report on Form 10-Q for the three months ended September 30, 2025, filed with the Securities and Exchange Commission on November 4, 2025.
• F4: The price reported is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.4050 to $14.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.